Skip to main content
. Author manuscript; available in PMC: 2011 Nov 21.
Published in final edited form as: Toxicol Appl Pharmacol. 2009 Oct 2;242(1):1–8. doi: 10.1016/j.taap.2009.09.018

Figure 6.

Figure 6

Figure 6

Effect of arginase inhibition on Arginase1 [A] and Arginase2 [B] content in Western blot images from C57BL/6 and NOS2−/− mice. Representative images of each treatment group are displayed with actinin content displayed below as a loading control. Variability of Arginase1 protein content in the C57BL/6 OVA group was observed in all 8 animals examined. This variability was not observed in any other treatment group.